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The AraC homolog ToxT coordinately regulates virulence gene expression in Vibrio cholerae. ToxT is required
for transcriptional activation of the genes encoding cholera toxin and the toxin coregulated pilus, among
others. In this work we focused on the interaction of ToxT with the tcpA promoter and investigated the
mechanism of ToxT-dependent transcriptional activation at tcpA. Deletion analysis showed that a region from
ⴚ95 to ⴙ2 was sufficient for ToxT binding and activation, both of which were simultaneously lost when the
deletion was extended to ⴚ63. A collection of point mutations generated by error-prone PCR revealed two small
regions required for ToxT-dependent transactivation. Binding studies performed with representative mutations showed that the two regions define sites at which ToxT binds to the tcpA promoter region, most likely as
a dimer. Results obtained by using a rpoA truncation mutation showed that ToxT-dependent activation at tcpA
involves the C-terminal domain of the RNA polymerase alpha subunit. A model of ToxT-dependent transcriptional activation at tcpA is proposed, in which ToxT interacts with two A-rich regions of tcpA centered at ⴚ72
and ⴚ51 and requires the alpha C-terminal domain of RNA polymerase.
tions. ToxR and ToxS have other roles in V. cholerae besides
virulence gene regulation (10, 43). One example is regulation
of the relative abundance of the porins OmpU and OmpT.
Transcription of ompU is positively regulated by ToxR, while
ompT is repressed by ToxR. This ToxR-dependent porin modulation has recently been shown to have an important role in
pathogenesis (54). When ompT is expressed in a ToxR⫹ strain
in place of ompU, the levels of ctx and tcp transcription decrease and colonization is reduced. It has been proposed that
the importance of porin regulation led to the recruitment of
ToxR as a regulator of the acquired pathogenicity island virulence genes, such as tcp and ctx (54).
A second pair of membrane-bound proteins, TcpP and
TcpH, have homology to ToxR and ToxS, respectively, and are
thought to function in a similar manner (22). TcpP and TcpH
are encoded on the TCP-ACF pathogenicity island, and their
expression is influenced by factors such as temperature and pH
in a manner that parallels what happens in tcp and ctx gene
expression (6). Transcription of the tcpPH operon is dependent
on two regulators which are encoded on the ancestral genome,
AphA and the LysR homolog AphB (35, 62).
ToxRS and TcpPH function cooperatively to activate expression of another TCP-ACF-encoded activator, ToxT (12, 22).
ToxT is required for activation of the tcp and ctx operons (3, 7),
as well as other genes in the virulence regulon, such as tcpI,
acfA, tagA, and tagD (12; Taylor, unpublished data). ToxT also
regulates its own expression through an autoregulatory loop (3,
70). ToxT therefore functions as a coordinate regulator of
virulence gene expression in V. cholerae by activating genes
encoded on both the TCP-ACF element and the CTX element
in response to environmental cues. In addition to the series of
activators involved in this regulatory cascade, the global regulators cyclic AMP receptor protein and H-NS have a negative
influence on virulence gene expression in V. cholerae (49, 61).
Both of these regulators influence expression of a number of

Vibrio cholerae is the etiological agent of the life-threatening
diarrheal disease cholera. This bacterium inhabits an aquatic
environmental niche when it is not infecting a human host and
is acquired through ingestion of contaminated food or drinking
water. V. cholerae colonizes the upper intestine of humans via
the toxin coregulated pilus (TCP) (25, 63), one of the organism’s two main virulence factors. The second major virulence
factor is cholera toxin (CT), which is responsible for the efflux
of fluids into the intestine that results in diarrhea (33). Expression of both TCP and CT is regulated by various environmental
factors, such as temperature, pH, osmolarity, bile, CO2, and
amino acids (reviewed in references 9 and 60). This regulation
by external stimuli ensures that TCP and toxin are expressed
only when they are needed (i.e., in the host). The genes required for TCP biogenesis are located on the Vibrio pathogenicity island (15, 34). The CT subunits are encoded on a separate genetic element, the lysogenic CTX bacteriophage (68).
These two elements are thought to have been acquired separately through horizontal gene transfer, and it has been shown
that CTX uses TCP as its receptor (68).
Regulation of genes encoding TCP and CT is controlled at
the level of transcription by a regulatory cascade referred to as
the ToxR virulence regulon (9, 12, 60). ToxR is a transmembrane protein with homology to the OmpR family of DNA
binding proteins (44) that, along with its partner ToxS, is encoded within the ancestral V. cholerae genome. ToxR directly
binds to DNA (44), while ToxS enhances the ability of ToxR to
form a transcriptionally active complex (11, 41, 52). The toxRS
operon is expressed constitutively under most growth condi-
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genes in the regulon. H-NS has been shown to function directly
at the ctx, toxT, and tcpA promoters (49). ToxT overrides the
negative effects of these regulators directly at the tcpA and ctx
promoters (49).
ToxT is a member of the AraC/XylS family of transcriptional
regulators (26, 50), a family made up almost exclusively of
activator proteins. AraC/XylS family members are characterized by a conserved stretch of amino acids at the C terminus,
which constitutes the DNA binding domain (reviewed in references 18 and 38). This region of homology contains two
helix-turn-helix (HTH) motifs, and crystal structures of AraC
family members have shown that these HTH motifs interact
with the DNA helix in the major groove (36, 55). Many AraC
family members have binding sites that are adjacent to or
overlap the ⫺35 region, and interactions between AraC family
members and RNA polymerase have been suggested (1, 18, 27,
28, 30, 31, 38). The N terminus of AraC family members is not
conserved and has been shown for some family members to be
involved in dimerization and binding of small effector molecules (18, 38).
Proteins in the AraC/XylS family fall into three main groups
depending on the types of genes that they regulate. Family
members that regulate carbon metabolism, such as AraC of
Escherichia coli, are known to respond to small effector molecules that bind to the N-terminal domain of the protein. In the
case of AraC, the effector molecule is arabinose. The members
of a second group of the AraC family regulate genes involved
in stress response. These proteins include SoxS, Rob, and
MarA, and they have been shown to function as monomers
(38). A third group, including ToxT, Rns of enterotoxigenic E.
coli (45), BfpT (PerA) of enteropathogenic E. coli (66), and
ExsA of Pseudomonas aeruginosa (29), regulate virulence gene
expression. These virulence regulators may respond to physical
cues, such as temperature and pH; only one virulence regulator
of the AraC/XylS family, UreR, has been shown to directly
respond to an effector molecule, urea (65). Recently, the effect
of bile on regulation of virulence genes in V. cholerae has been
investigated (20, 57). The addition of bile to growth media
repressed transcription of tcp and ctx but, paradoxically, induced transcription of toxT. This suggests that bile may directly
influence the transcriptional activity of the ToxT protein itself,
perhaps by binding to the N-terminal domain (57).
Several promoters in V. cholerae that are regulated by ToxT
have been characterized, and there is no obvious consensus
sequence that can be proposed as the ToxT binding site. Many
AraC/XylS family members recognize asymmetric sequences
(18, 45), which makes it difficult to predict the binding sites of
these proteins. We have focused most of our work in this
regard on defining the cis-active requirements for ToxT interaction at the tcp operon promoter and investigating the mechanism of ToxT-dependent transcriptional activation at tcpA.
Using a promoter deletion analysis along with PCR-based mutagenesis of the promoter region, we found that ToxT interacts
with two A-rich regions centered at ⫺72 and ⫺51. The mutations that prevent ToxT-mediated activation of tcpA expression
are clustered within these two regions, which we have designated site I (⫺72) and site II (⫺51). Using gel shift analysis, we
determined that a His-tagged version of ToxT binds to a probe
that includes both site I and site II. ToxT does not detectably
bind to either site I or site II alone. ToxT also does not
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detectably bind to probes carrying various point mutations in
site I, but it does bind weakly to a probe carrying a point
mutation in site II. The region proposed for ToxT binding at
the tcp operon promoter does not contain any obvious dyad
symmetrical sequences. Upon binding to these sites ToxT appears to activate transcription of the tcp operon via a mechanism that involves the alpha C-terminal domain (␣CTD) of
RNA polymerase.
MATERIALS AND METHODS
Bacterial strains, media, and antibiotics. The strains and plasmids used in this
study are listed in Table 1. V. cholerae and E. coli strains were maintained at
⫺70°C in Luria-Burtani (LB) medium (40) containing 30% (vol/vol) glycerol. E.
coli was grown in LB medium with a starting pH of either 7.0 or 6.5 at 37 or 30°C.
V. cholerae was grown at 30°C in LB medium with a starting pH of 6.5. Antibiotics were used at the following concentrations: ampicillin, 100 g/ml; chloramphenicol, 34 g/ml; and streptomycin, 100 g/ml. X-Gal (5-bromo-4-chloro-3indolyl-␤-D-galactopyranoside) was added to LB agar at a concentration of 40
g/ml. Arabinose was added to the growth media at a final concentration of
0.02%.
Plasmid and strain construction. The tcpA-lacZ deletion series in pRS415 was
constructed as follows. The tcpA promoter fragments for pAJA3, pRH82,
pRH72, pAJA2, pAJA1, and pRH8 were amplified by PCR from V. cholerae
O395 genomic DNA by using 5⬘ primers TcpHAA1 (5⬘-AAAAGAATTCCGC
CTAGATAGTGTGTGA-CG-3⬘), RH11 (5⬘-GATCGGAATTCGCACGAGA
CGAACACTGTC-3⬘), RH04 (5⬘-GATCGGAATTCAATTTCGATCTCCACT
CCGG-3⬘), RH03 (5⬘-GACTGAATTCTTGAATTGAATAAGTTGGCC-3⬘),
RT35 (5⬘-AAAACTCGAGGTGCGTGAATGTTACTCGTG-3⬘), and RH01
(5⬘-ATGCGAATTCCTTTCAATGCAAGTGTG-3⬘). The 3⬘ primer used for all
these constructs was RTAA36 (5⬘-AAAAGGATCCACACGCACATTTAACC
ACAC-3⬘). The tcpA promoter fragment for pRH98 was amplified from O395
chromosomal DNA by using primers RH12 (5⬘-GATCGAATTCAAAAAACA
CAGCAAAAAATG-3⬘) and RH13 (5⬘-GACTGGATCCATGTAACTCCACC
ATTTTAC-3⬘). The products were cloned into the EcoRI-BamHI site of pRS415
and verified by PCR. toxT was provided on plasmid pTSS-5.
tcpA-lacZ fusions in pAJA3, pAJA2, pAJA1, pRH8, pRH98, pRH80, pCJ1.3,
and pCJ10.4 were recombined onto RS45 (59) and lysogenized into MC4100 to
create strains RRH100, RRH115, RRH131, RRH113, RRH114, RRH101,
RRH102, and RRH103, respectively. Single-copy lysogens were confirmed by
PCR (53). pTSS-5 was introduced into each strain by calcium chloride transformation.
Plasmid pRH81 was constructed in the following manner. The toxT gene was
amplified from O395 chromosomal DNA by using primers RH07 (5⬘ AGCCAT
GGCACACCACCACCACCACCACATGATTGGGAAAAAATCTTTTC-3⬘),
which adds a six-His tag on the N-terminal end, and RH08 (5⬘-AGCTTCTAG
ACCCAAAATCAGTGATACAATCG-3⬘). The product was cloned into the
NcoI-XbaI site of pBAD22 and confirmed by PCR and sequencing.
Plasmids pRH170 and pRH171 were constructed in the following manner. For
pRH170, the entire rpoA gene was amplified from O395 chromosomal DNA by
using primers RH17 (5⬘-GATCCTGCAGTTATCTTCAGCGATTGACG-3⬘)
and RH19 (5⬘-GATCGGATCCCGAACAATTGATCGTCGAGC-3⬘). The
product was cloned into the PstI-BamHI site of pMMB66EH and confirmed by
both PCR and sequencing. For pRH171, primers RH17 and RH18 (5⬘-GATCC
TGCAGTTATTACTCGTGCTGGTTCTTAAGATCTACGAACGCATCC-3⬘)
were used to amplify the truncated rpoA gene (amino acids 1 to 235) from O395
chromosomal DNA. Primer RH18 encodes a five-amino-acid polar linker (KNQHE), followed by two ochre stops at the 5⬘ end. The linker was added for
stabilization purposes (39, 52). The product was also cloned into the PstI-BamHI
site of pMMB66EH and confirmed by PCR and sequencing. Both pRH170 and
pRH171 were introduced into V. cholerae strains by mating (64) from strain
SM10pir.
␤-Galactosidase assays. All ␤-galactosidase assays (40) were carried out after
growth in LB medium (pH 6.5) at 30°C. Strains carrying tcpA-lacZ fusions were
assayed following overnight growth with aeration, while assays with toxT-lacZ
fusion strains were performed by using mid-log-phase cultures. ␤-Galactosidase
activity was expressed in Miller units (40).
Random PCR mutagenesis. Random PCR mutagenesis was carried out as
previously described by Cadwell and Joyce (5) and Fromant et al. (16). Specifically, for the method of Cadwell and Joyce, the PCR mixtures contained 7 mM
MgCl2, 0.2 mM dATP, 0.2 mM dGTP, 1 mM dTTP, 1 mM dCTP, 0.5 mM MnCl2,

ToxT-DEPENDENT ACTIVATION OF tcpA

VOL. 184, 2002

5535

TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid

E. coli strains
CC118
MC4100
SM10pir
AA60
AJA1
AJA2
AJA3
RRH26
RRH72
RRH81
RRH82
RRH98
RRH100
RRH102
RRH103
RRH113
RRH114
RRH115
RRH131
V. cholerae strains
O395 Sm
CG842
MBN135
MBN142
MBN168
RRH175
RRH176
RRH178
RRH179
RRH181
RRH182
MBN032
RRH197
RRH201
Plasmids
pTSS-5
pRS415
pAJA1
pAJA2
pAJA3
pRH8
pRH72
pRH82
pRH98
pCJ1.3
pCJ10.4
pBAD22
pRH81
pMMB66EH
pRH170
pRH171

Characteristic(s)

Reference or source

araD139 ⌬(ara leu)7697 ⌬lacX74 ⌬phoA20 galE galK thi rpsE rpoB argE(Am) recA1
F⫺ araD139 ⌬(argF-lac)U169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR
thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (pir)
CC118, pTSS-5
CC118, pAJA1
CC118, pAJA2
CC118, pAJA3
CC118, pRH8
CC118, pRH72
CC118, pRH81
CC118, pRH82
CC118, pRH98
MC4100 (tcpA-lacZYA) (⫺458/⫹2)
MC4100 (tcpA-lacZYA) (⫺162/⫹2), T to A at ⫺38
MC4100 (tcpA-lacZYA) (⫺162/⫹2), A to T at ⫺50
MC4100 (tcpA-lacZYA) (⫺95/⫹2)
MC4100 (tcpA-lacZYA) (⫺63/⫹72)
MC4100 (tcpA-lacZYA) (⫺162/⫹2)
MC4100 (tcpA-lacZYA) (⫺118/⫹2)

37
58
43
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

Classical Ogawa, Smr
O395 Sm ⌬lacZ
CG842 tcpA-lacZ
MBN135 ⌬toxT
MBN135 ⌬toxT ⌬hns
MBN135 (pRH170)
MBN135 (pRH171)
MBN142 (pRH170)
MBN142 (pRH171)
MBN168 (pRH170)
MBN168 (pRH171)
CG842 toxT-lacZ
MBN032 (pRH170)
MBN032 (pRH171)

63
8
M. Nye
M. Nye
M. Nye
This study
This study
This study
This study
This study
This study
49
This study
This study

pACYC184 toxT⫹, Cmr
lacZYA transcriptional fusion vector, Apr
pRS415::(tcpA-lacZYA) (⫺118/⫹2)
pRS415::(tcpA-lacZYA) (⫺162/⫹2)
pRS415::(tcpA-lacZYA) (⫺458/⫹2)
pRS415::(tcpA-lacZYA) (⫺95/⫹2)
pRS415::(tcpA-lacZYA) (⫺230/⫹2)
pRS415::(tcpA-lacZYA) (⫺310/⫹2)
pRS415::(tcpA-lacZYA) (⫺63/⫹72)
pRS415::(tcpA-lacZYA) (⫺162/⫹2), T to A at ⫺38
pRS415::(tcpA-lacZYA) (⫺162/⫹2), A to T at ⫺50
Expression plasmid, Apr
pBAD22 six-His toxT
Expression plasmid, Apr
Full-length rpoA in pMMB66EH
rpoA⌬235 in pMMB66EH

3
59
This
This
This
This
This
This
This
This
This
21
This
17
This
This

and 5 U of Taq polymerase. For the method of Fromant et al., the PCR mixtures
contained 4.2 mM MgCl2, 0.2 mM dGTP, 0.2 mM dCTP, 0.2 mM dTTP, 3.4 mM
dATP, and 5 U of Taq polymerase. Each PCR consisted of 30 cycles of 94°C for
1 min, 45°C for 1 min, and 72°C for 1 min with primers RH03 and RTAA36 (see
above). pAJA2 plasmid DNA was used as a template. Five separate pools were
generated with each method. Pooled PCR products were purified on spin columns (Qiagen), digested with EcoRI and BamHI, gel purified, and ligated into
pRS415 to create lacZ fusions. The resulting pools of mutant constructs were
electroporated into E. coli strain AA60, which carries toxT on plasmid pTSS-5.
Colonies that appeared pink and shiny on 1% lactose–MacConkey agar plates
were chosen for further study. Plasmid DNA was isolated from mutants by using
Qiagen kits and was backcrossed into AA60 to confirm the phenotype. PCR was
used to verify the presence of the desired insert. Inserts were sequenced by using
automated fluorescence dye sequencing (Molecular Core Facility, Dartmouth
Medical School).

study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study

study
study
study
study
study
study
study
study
study
study
study
study

Purification of ToxT, SDS-PAGE, and immunoblotting. The toxT gene was
inserted into pBAD22 under control of the arabinose-inducible promoter paraBAD, and this construct was transformed into E. coli CC118. The resulting strain,
RRH81, was grown to the mid-log phase at 30°C, and then arabinose was added
to a final concentration of 0.02% and the strain was induced for 4 h at 30°C. Cell
pellets were resuspended in extraction buffer (50 mM sodium phosphate, 300
mM NaCl; pH 7.0) and lysed by passage through a French pressure cell two or
three times. Following a clarifying spin at 10,000 rpm in a Sorvall SS34 rotor for
20 min, supernatant and pellet fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Supernatants containing
His-tagged ToxT were passed over Talon metal affinity resin (Clontech), and
after extensive washing, ToxT was eluted with elution buffer (50 mM sodium
phosphate, 300 mM NaCl, 150 mM imidazole). Column fractions were analyzed
by SDS-PAGE, and fractions containing ToxT were pooled and dialyzed overnight against TEN buffer (0.1 M NaCl, 10 mM Tris-HCl [pH 7.5], 1 mM EDTA
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FIG. 1. ToxT-dependent activation of tcpA-lacZ promoter deletions in E. coli. (A) Strains with no ToxT (shaded bars) or strains with the
ToxT-expressing plasmid pTSS-5 (solid bars) were grown overnight in LB medium (pH 6.5) at 30°C. Promoter deletions are carried on plasmid
pRS415. The values are averages for at least two independent experiments. (B) tcpA-lacZ deletion series. Most promoter deletions are within a
promoter fragment that extends to position ⫹2 relative to the start of transcription; the only exception is the ⫺63 deletion, which extends to ⫹72.
The level of activation in the presence of ToxT is indicated for each deletion.

[pH 8]) containing 1 mM dithiothreitol. Protein concentrations were determined
by the bicinchoninic acid procedure (Pierce). His-tagged ToxT in crude extracts
and as pure protein was visualized by immunoblotting as follows. Proteins were
transferred to nitrocellulose membranes, probed with anti-TetraHis antibody
(Qiagen), and visualized by using ECL detection reagents (Amersham Pharmacia). Protein was stored at ⫺70°C in 10% glycerol.
Gel mobility shift assays. PCR products of tcpA promoter regions were end
labeled by using digoxigenin (DIG) (Gel Shift kit; Roche). The ⫺95/⫹2, CJ10.4,
CJ3.3, CJ2.6, and F4.2 probes were amplified from V. cholerae O395 chromosomal DNA or plasmids by using primers RH01 and RTAA36, the ⫺63/⫹2
probe was amplified by using primers RH12 and RTAA36, and the ⫺43/⫹2
probe was amplified by using primers RH16 (5⬘-GATCGAATTCGACATCTG
TCAATTGTAGGT-3⬘) and RTAA36. The site I probe (probe ⫺162/⫺51) was
amplified from chromosomal DNA by using primers RH24 (5⬘-GTACTGCTG
TGTTTTTTTATTTTTTTAATAAC-3⬘) and RH03. Probes were purified on
agarose gels and extracted by using Gel Extraction kits (Qiagen). One microgram
of probe was used for each labeling reaction. Labeled probe was resuspended in
TEN buffer to a final concentration of 5 to 10 ng/l. Five nanograms of labeled
probe plus various amounts of pure His-tagged ToxT were used for each binding
reaction. Also, 500 ng of calf thymus nonspecific competitor DNA was added to
each reaction mixture. Binding reactions were carried out in binding buffer (10
mM Tris-HCl [pH 7.5], 100 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 200 g
of bovine serum albumin per ml, 10% glycerol), and the reaction mixtures were
incubated at 30°C for 30 min. Loading buffer without bromphenol blue was
added, and samples were loaded onto a preelectrophoresed 6% native polyacrylamide gel. Gels were electrophoresed in 1⫻ Tris-borate-EDTA at 120 V and
4°C. DNA was transferred to a positively charged nylon membrane (Roche) by
electroblotting, cross-linked by using a UV Stratalinker (Stratagene), and visualized with an anti-DIG antibody by chemiluminescent detection by using reagents provided in the DIG kit (Roche).

RESULTS
Deletion series of the tcpA promoter region defines a minimal region required for ToxT-dependent activation. ToxT has
previously been shown to directly activate tcpA expression with
an E. coli host (3, 12). In order to delineate the cis requirements for activation by ToxT, a deletion series encompassing a
region from ⫺458 to ⫺63 of the tcpA promoter was constructed in the cloning vector pRS415, which carries a promoterless lacZ gene downstream of the cloning site. The resulting
tcpA-lacZ fusion constructs were transformed into E. coli lacZ
deletion strain CC118, and toxT was provided on the pACYC184 derivative pTSS-5. The ability of ToxT to activate

each tcpA promoter deletion was examined by determining the
induction value for activated levels (ToxT⫹) compared with
basal levels (ToxT⫺) for each deletion construct. As shown in
Fig. 1, ToxT was able to activate transcription for the entire
deletion series except pRH98, which is deleted to position ⫺63
relative to the transcriptional start site of tcpA. This suggests
that ToxT binds to a region of the tcpA promoter between
positions ⫺95 and ⫹2, perhaps either upstream of or encompassing position ⫺63. This region is extremely A rich. The
promoter fusions upstream of ⫺162 showed decreased levels
of basal transcription compared to the levels of shorter fusions,
indicating that there was a possible repressor binding site upstream of this position. The histone-like nuclear structuring
protein H-NS has been shown to repress transcription of tcpA
(49), and it has been proposed that this protein binds to one or
more sites in this region of the promoter. ToxT partially overcomes the negative effect of H-NS at tcpA and ctxA (49).
Point mutations in the tcpA promoter that affect activation
by ToxT cluster in three regions. To further define the location
of the ToxT binding site at the tcpA promoter, PCR mutagenesis was carried out to create random point mutations in the
promoter region. The region from ⫺162 to ⫹2 of the tcpA
promoter was chosen as the template for mutagenic PCR since
it included the region from ⫺95 to ⫺63, as well as flanking
regions that might influence activation. Five separate pools of
mutant PCR products were generated by the two procedures
described in Materials and Methods. These products were
cloned into pRS415 to create lacZ fusion constructs that were
then transformed into AA60, an E. coli strain harboring toxT
on pTSS-5. The transformants were plated on 1% lactose–
MacConkey agar plates and grown at 30°C. Wild-type tcpAlacZ fusion strains were dark red on these plates due to full
activation by ToxT. White colonies lacked the promoter insert.
Colonies harboring plasmids that were potentially defective for
activation had a shiny pink appearance and white edges. Transformants that displayed this phenotype were restreaked on 1%
lactose–MacConkey agar plates, and the presence of the tcpA
promoter insert was confirmed by colony PCR. Plasmid DNA
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FIG. 2. Sequences of single-point mutants with mutations in the region from ⫺80 to ⫺30, aligned with the sequence of the wild-type tcpA
promoter. Base pair changes or deletions are shown; wild-type bases are indicated by dots. Strains carrying the tcpA-lacZ fusions on plasmid
pRS415 with no ToxT or with the ToxT-expressing plasmid pTSS-5 were grown overnight in LB medium (pH 6.5) at 30°C. The ␤-galactosidase
activity (in Miller units) and the level of activation (act.) in the presence of ToxT are shown for each strain. The values are averages for at least
two independent experiments.

was isolated and backcrossed into AA60 to confirm that the
activation defect was linked to the tcpA promoter-containing
plasmid. ␤-Galactosidase assays were performed on the mutant strains, and the level of activation by ToxT for each mutant was compared to that of the wild-type strain. The mutants
could be separated into two categories. The mutants in the first
category showed an overall decreased level of transcription,
particularly decreased activation by ToxT, which is the result
expected for a mutation that disrupts activator function. The
mutants in the second category showed a decreased level of
basal transcription but retained wild-type levels of activation by
ToxT, as expected for a mutation which disrupts RNA polymerase-DNA interactions. The majority of the mutants fell
into the first category, but two mutants that are discussed
below fell into the second category. It was found that for all of
the mutants in the first category, ToxT was able to activate only
one- to twofold compared with basal levels of transcription,
compared to the fivefold activation observed for the wild type
and for mutants in the second category.
Twenty representative mutants were sequenced, and their
sequences were aligned with the wild-type sequence for the
region. Seven of the mutants had a single base pair substitution
or deletion, while the other 13 mutants had two or more base
pair substitutions or deletions. The point mutations clustered
in three distinct regions: the ⫺35 region, a region centered at
⫺60, and an upstream region centered at ⫺117. No single
mutations in the ⫺117 region that did not have an accompanying mutation around ⫺60 or ⫺35 were isolated in our mutagenesis experiments, suggesting that the region centered at
⫺117 is not in and of itself critical for activation by ToxT. This
hypothesis is consistent with the results of the deletion analysis.
Figure 2 shows the sequences of 12 of the mutants that have
single mutations in either the ⫺60 or ⫺35 region. Ten of the
mutants shown in Fig. 2 fall into the first category of mutants
with decreased levels of activation by ToxT. All 10 of these
mutants have single base pair substitutions or deletions in the
region centered at ⫺60, and ToxT is able to activate only oneto twofold compared with the basal levels, compared to the
fivefold activation by the wild type. The mutations around ⫺60
cluster in two regions separated by more than 10 bp, suggesting
that they may define two distinct sites required for ToxT func-

tion. The single base pair deletions may also affect the spacing
and rotation of these sites with respect to each other or the
RNA polymerase binding site. Two of the mutants shown in
Fig. 2 belong in the second category of mutants with decreased
levels of basal transcription and wild-type levels of activation
by ToxT. One of these mutants, CJ1.3, was found to have a
single point mutation within the putative ⫺35 region. The base
pair change from T to A alters the sequence of the putative
⫺35 hexamer further from the consensus TTGACA sequence.
This mutant showed decreased levels of both basal and activated transcription compared to the wild-type levels, but the
level of activation by ToxT was comparable to that of the wild
type (3.7-fold versus 5-fold) (Fig. 2). Because the mutation falls
in the putative ⫺35 region and has only a minor effect on
ToxT-mediated activation, we hypothesized that this point mutation affects RNA polymerase binding and does not greatly
affect ToxT activity. The other mutant in the second category,
CJ2.3, has only a defect in the basal level of transcription. ToxT
is able to activate to wild-type levels (8,360 U) (Fig. 2). This
mutant has a single base pair change, A to G at ⫺33, within the
putative ⫺35 consensus region, which alters the sequence further from the consensus sequence. Since the only defect is a
defect in basal transcription, we hypothesized that the point
mutation of this mutant, like the CJ1.3 mutation, also affects
the RNA polymerase binding site and the presence of ToxT is
able to overcome this defect and provide full levels of activated
transcription.
Analysis of a single T-to-C point mutation at ⫺117 and
creation of an internal deletion of the region from ⫺140 to
⫺95 allowed us to determine that the upstream region centered at ⫺117 is not required for activation by ToxT (data not
shown). The region closer to the transcriptional start site, centered at ⫺60, is essential for activation by ToxT, as shown by
the promoter deletion series and the random point mutations.
ToxT activation of single-copy chromosomal tcpA promoter
fusions in E. coli. All of the experiments described above were
carried out with multicopy plasmids in E. coli. In order to
confirm that the results obtained were not due to alterations in
plasmid supercoiling or multicopy effects, several representative tcpA-lacZ fusions were integrated into the E. coli chromosome as  lysogens for further analysis. These included the
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FIG. 3. ToxT-dependent activation of representative tcpA-lacZ
promoter constructs as  lysogens integrated into the E. coli chromosome. Strains with no ToxT or strains with the ToxT-expressing plasmid pTSS-5 were grown overnight in LB medium (pH 6.5) at 30°C. The
values are averages for at least two independent experiments.

construct from ⫺458 to ⫹2 (pAJA3), the construct from ⫺162
to ⫹2 (pAJA2), the construct from ⫺95 to ⫹2 (pRH8), and
the construct from ⫺63 to ⫹72 (pRH98). A single point mutation in the ⫺35 region (CJ1.3) and a single point mutation at
⫺50 in the putative ToxT binding site (CJ10.4) were also used.
Single copies of these six constructs were integrated into the
chromosome of E. coli MC4100 as RS45 derivatives (59).
ToxT was provided from plasmid pTSS-5, and ␤-galactosidase
assays were performed. The overall trends followed what was
observed with multicopy plasmids (Fig. 3). ToxT-dependent
activation was lost with the fusion at ⫺63 to ⫹72. ToxT was not
able to activate at levels significantly above basal levels when
the A-to-T substitution at ⫺50 was present but was able to
activate in the strain containing the T-to-A substitution at ⫺38.
Similar motifs at other ToxT-regulated promoters in V. cholerae. Data obtained with the deletion series and random point
mutations suggest that the ToxT binding site at the tcpA promoter is located in an A-rich region from ⫺82 to ⫺45 relative
to the transcriptional start site. Other ToxT-activated promoters were examined for similar motifs. An alignment of the
putative ⫺10 regions of the tcpA, tcpI, tagA, and ctxA promoters is shown in Fig. 4. The first three promoters, tcpA, tcpI, and
tagA, are all very A rich. The tcpI promoter closely resembles
tcpA in that there is a long A tract located around ⫺65 relative
to the transcriptional start site and a shorter A tract located
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closer to the ⫺35 region. The tagA promoter has only one A
tract, and it is located proximal to the ⫺35 region. The similarity among these three ToxT-regulated promoters, together
with the results of the genetic analysis of the tcpA promoter,
suggests that ToxT may interact with these A-rich regions. The
sequence upstream of ctx does not resemble the sequence
upstream of tcpA, tcpI, or tagA; however, regulation at the ctxA
promoter is much different from regulation at the other three
promoters in that ctxA is regulated by both ToxT and the
membrane-bound activator ToxR (12, 42, 49).
His-tagged ToxT binds directly to the tcpA promoter in vitro.
The ability of ToxT to interact with the region of the tcpA
promoter determined by genetic means was confirmed by gel
shift analysis by using six-His-tagged ToxT. Purified His-tagged
ToxT was used in gel mobility shift assays with DIG-labeled
fragments of the tcpA promoter, as described in Materials and
Methods. As shown in Fig. 5, ToxT was able to bind to and
shift the region of the tcpA promoter from ⫺95 to ⫹2, which
contains both of the A-rich regions identified by the deletion
series and point mutations. ToxT was not able to shift the
region of the tcpA promoter from ⫺63 to ⫹2, in which one-half
of the promoter-distal A tract is removed. This is consistent
with the data described above that show that this region is
unresponsive to transcriptional activation by ToxT (Fig. 1).
These results suggest that ToxT requires the promoter-distal A
tract to bind and activate and cannot bind to the promoterproximal A tract alone. ToxT also does not bind to a nonspecific probe encompassing the region from ⫹1 to ⫹130 of the
tcpP promoter (Fig. 5), further demonstrating that the promoter-distal site-dependent binding is specific.
Next we wished to examine whether the lack of activation
resulting from various point mutations in the tcpA promoter
was due to a defect in ToxT binding. CJ3.3 has two mutations
in the promoter-distal site and one mutation in the promoterproximal site, CJ2.6 has one mutation in the promoter-distal
site and one mutation in the promoter-proximal site, and F4.2
has one mutation in the promoter-distal site (Fig. 6A). ToxT
was not able to detectably bind to a probe containing the
mutations (Fig. 6B), suggesting that these point mutations are
activation defective because they are binding defective. To
specifically assess the role of the promoter-proximal site in
binding, we used CJ10.4, which has an A-to-T mutation at ⫺50
in this A tract. ToxT was able to bind to this probe, but with
less avidity than to a wild-type probe (Fig. 6C), which is consistent with the decreased activation of this mutation (Fig. 2).
To further investigate the relative roles of the two A tracts in
ToxT binding, a probe was constructed from ⫺162 to ⫺51
containing the entire promoter-distal site but only one-half of

FIG. 4. Alignment of the tcpA promoter with other V. cholerae promoters regulated by ToxT. Sequences were aligned by using the ⫺10
consensus sequence. The tcpI start site has been described previously (47), as have the tcpA start site (3) and the ctxA start site (51). The tagA start
site is hypothetical.
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FIG. 5. Six-His-tagged ToxT binds to tcpA promoter fragments in gel mobility shift assays. (A) Lanes 1 to 3, ⫺95/⫹2 tcpA probe (lane 1, no
protein; lane 2, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 3, 300 ng [9.3 pmol] of six-His-tagged ToxT); lanes 4 to 6, ⫺63/⫹2 tcpA probe (lane
4, no protein; lane 5, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 6, 300 ng [9.3 pmol] of six-His-tagged ToxT); lanes 7 to 9, ⫹1/⫹130 tcpP probe
(lane 7, no protein; lane 8, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 9, 300 ng [9.3 pmol] of six-His-tagged ToxT). (B) Diagram showing the
positions of tcpA promoter fragments used in the gel shift analysis. The ⫺95/⫹2 probe includes both A tracts, while the ⫺63/⫹2 probe includes
one-half of the distal A tract and the entire proximal A tract.

the promoter-proximal site. The inability of ToxT to produce a
detectable shift of this probe suggests that ToxT is not able to
bind to the distal site in the absence of the proximal site (Fig.
6C). This, coupled with the results of the analysis of the distal
site presented above, suggests that ToxT requires the presence
of both A tracts for binding.
ToxT requires ␣CTD of RNA polymerase to activate transcription at tcpA. It has been demonstrated that many AraC
family members require the ␣CTD of RNA polymerase to
activate transcription at their respective promoters (27, 30, 32,
38, 56). We tested the requirement for ␣CTD for ToxT-dependent transcriptional activation at tcpA by performing a genetic analysis similar to that described by Holcroft and Egan
(27). The region of the V. cholerae rpoA gene corresponding to
residues 1 to 235 was amplified from O395 chromosomal DNA
and cloned under control of an isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible promoter. This resulted in a truncated ␣ subunit that was missing the C-terminal domain. We
hypothesized that when the truncated ␣ subunit is overexpressed in V. cholerae, it assembles with RNA polymerase
subunits expressed from the chromosome and acts as a dominant negative allele with respect to promoters at which ␣CTD
has a role in expression. This hypothesis is based on previous
experiments performed with E. coli (23). A full-length rpoA
construct was also constructed as a control. Each of the rpoA
constructs was introduced into V. cholerae strains carrying a
chromosomal tcpA-lacZ fusion. In a wild-type background,
overexpression of the truncated ␣ subunit resulted in an 11fold decrease in tcpA-lacZ expression compared to the expression when a full-length ␣ subunit was overexpressed (Fig. 7A).
This effect was not seen in a ⌬toxT background or a ⌬toxT ⌬hns
background, which was used to elevate the level of tcpA expression in the ⌬toxT background (Fig. 7A). These results
suggest that only ToxT-dependent transcription and not basal

transcription of the tcpA promoter depends upon the ␣ subunit
of RNA polymerase.
To determine whether the 11-fold defect in transcription of
tcpA-lacZ was due to a direct effect of the truncated ␣CTD at
the tcpA promoter and not to the effects of other promoters
upstream in the regulatory cascade, we expressed ToxT from
the ␣CTD-independent tetR promoter using plasmid pTSS-5.
These experiments were carried out with E. coli since the tetR
promoter is not expressed well in V. cholerae. E. coli tcpAlacZ strain RRH115 (⫺162/⫹2) carrying either full-length
rpoA or ⌬235 rpoA on pMMB66EH and pTSS-5 as a source of
ToxT was assayed by performing ␤-galactosidase assays. We
found that when ToxT was expressed from an ␣CTD-independent promoter, there was an approximately fourfold defect in
tcpA-lacZ transcription due to overexpression of ⌬235 rpoA
(Fig. 7B). These results also suggest that ToxT interacts with
␣CTD to activate transcription at tcpA. Due to the difference
between the 11-fold defect in V. cholerae when ToxT was expressed from its own promoter and the 4-fold defect in E. coli
when ToxT was expressed from the tetR promoter, we introduced the rpoA constructs into a V. cholerae strain carrying a
chromosomal toxT-lacZ fusion. We observed a twofold defect
when the dominant negative allele was overexpressed (data not
shown). These results suggest that ␣CTD has a role at the toxT
promoter, perhaps through an interaction with ToxR or TcpP.
DISCUSSION
AraC family members can be divided into different categories based on the types of genes that they regulate, such as the
genes involved in sugar catabolism, stress response, and bacterial pathogenesis. It has been shown that family members
involved in the regulation of sugar catabolism, such as AraC
itself, function as dimers and have both a C-terminal DNA
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FIG. 6. Gel mobility shift assays with various tcpA promoter mutants. (A) Sequences of mutant probes used in binding studies. Base pair
changes are underlined. Most of the probes are from ⫺95 to ⫹2; the only exception is the probe from ⫺162 to ⫺51. WT, wild type. (B) Lanes
1 and 2, ⫺95/⫹2 tcpA probe (lane 1, no protein; lane 2, 150 ng [4.6 pmol] of six-His-tagged ToxT); lanes 3 and 4, CJ3.3 probe (lane 3, no protein;
lane 4, 150 ng [4.6 pmol] of six-His-tagged ToxT); lanes 5 and 6, CJ2.6 probe (lane 5, no protein; lane 6, 150 ng [4.6 pmol] of six-His-tagged ToxT);
lanes 7 and 8, F4.2 probe (lane 7, no protein; lane 8, 150 ng [4.6 pmol] of six-His-tagged ToxT). (C) Lanes 1 to 3, ⫺95/⫹2 tcpA probe (lane 1, no
protein; lane 2, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 3, 300 ng [9.3 pmol] of six-His-tagged ToxT); lanes 4 to 6, CJ10.4 probe (lane 4,
no protein; lane 5, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 6, 300 ng [9.3 pmol] of six-His-tagged ToxT); lanes 7 to 9, site I probe (lane 7,
no protein; lane 8, 150 ng [4.6 pmol] of six-His-tagged ToxT; lane 9, 300 ng [9.3 pmol] of six-His-tagged ToxT).

binding domain and an N-terminal dimerization domain. The
N-terminal domain also functions to bind regulatory cofactors,
such as sugar molecules. These proteins have binding sites that
overlap the ⫺35 position (class II promoters) (38). Family
members such as Rob, MarA, and SoxS regulate genes involved in stress response and function as monomers. These
proteins can have binding sites that are upstream of the ⫺35
position (class I promoters) or overlap the ⫺35 position (class
II promoters) (30, 38). ToxT belongs to the subgroup of AraC
homologs that regulate virulence gene expression. Less is
known about this subgroup than about any other subgroup, but
the members have been shown to activate transcription at both
class I and class II promoters. The tcpA promoter appears to be
a class I promoter since ToxT binds upstream of the ⫺35
position. We propose that the primary binding site does not

overlap the ⫺35 position for the following reasons. A point
mutation at ⫺38 (CJ1.3) affects overall transcription but does
not affect the level of activation by ToxT (Fig. 2), suggesting
that this mutation interferes only with RNA polymerase binding. It has been shown that SoxS requires only the ␣CTD of
RNA polymerase to activate transcription at promoters where
the binding site does not overlap the ⫺35 position (i.e., class I
promoters) (30). We have shown that ToxT requires the RNA
polymerase ␣CTD to activate transcription at tcpA (Fig. 7).
Furthermore, a recent paper by Yu et al. showed that ToxT
protects the region from ⫺84 to ⫺41 of tcpA in DNase I
protection assays (69). This footprint does not overlap the
putative ⫺35 site and is consistent with the data presented
here. Munson and Scott have recently demonstrated that the
AraC homolog Rns from enterotoxigenic E. coli requires a
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FIG. 7. Effects of dominant negative RNA polymerase alpha subunit on tcpA-lacZ expression in V. cholerae (A) and E. coli (B). (A) Cultures
of MBN135 (tcpA-lacZ), MBN142 (tcpA-lacZ ⌬toxT), or MBN168 (tcpA-lacZ ⌬toxT ⌬hns) carrying either pRH170 (full-length rpoA) or pRH171
(rpoA ⌬235) were grown overnight in LB medium (pH 6.5) at 30°C with or without 0.04 mM IPTG. The values are averages for at least two
independent experiments. WT, wild type. (B) Cultures of RRH115 (tcpA-lacZ ⫺162/⫹2) carrying no plasmid or pTSS-5 and either pRH170 or
pRH171 were grown overnight in LB medium (pH 6.5) at 30°C with or without 0.04 mM IPTG. The values are averages for at least two
independent experiments.

binding site downstream of the transcriptional start site to
activate transcription at its own promoter (46). We have no
indication that ToxT binds downstream of tcpA; in fact, our
tcpA-lacZ fusions ended at ⫹2, which suggests that ToxT does
not require downstream sequences to activate expression from
the tcpA promoter.
The binding site of ToxT at tcpA consists of two A-rich
regions on the sense strand. Deletions of a single A residue or
base pair substitutions in these A-rich regions and the surrounding DNA interfere with ToxT-dependent transcriptional
activation and binding. There is no obvious dyad symmetry in
the binding site, but AraC homologs tend to recognize asymmetric binding sites (18, 45). Two AraC homologs in particular
have been shown to bind to A-rich DNA sequences. ExsA from
P. aeruginosa binds to a consensus sequence (TXAAAAXA)
located around ⫺50 relative to the transcriptional start site
(29). BfpT (PerA) from enteropathogenic E. coli requires an
A-rich region from ⫺85 to ⫺46 of the bfpA promoter to activate transcription, and deletions of As in this region were
found to negatively affect BfpT-dependent transcriptional activation (4). BfpT is particularly interesting because like ToxT,
this protein regulates genes encoding a type IV pilus (bundleforming pilus) (4).
Many transcriptional activators have been shown to interact
with different subunits of RNA polymerase to activate transcription (67). There are data which suggest that various AraC
homologs require the ␣CTD of RNA polymerase (1, 27, 30, 32,
38, 56) at class I promoters. In this paper we present data
obtained by using a truncated alpha subunit which suggest that
ToxT requires ␣CTD to activate transcription at tcpA. Our
experiments also indicated that the ␣CTD does not seem to be
required for basal transcription at tcpA. This implies that the

A-rich sequence upstream of tcpA does not act as an UP
element. UP elements are A-T-rich sequences that can bind
␣CTD and stimulate transcription independent of activator
proteins (14, 19). UP elements consist of two subsites, a promoter-proximal subsite and a promoter-distal subsite. The
proximal subsite is typically centered at ⫺40 and has a consensus 5⬘-AAAAAARNR-3⬘ sequence, while the distal subsite
is centered at ⫺50 and has a consensus 5⬘-AWWWWWTTTT
T-3⬘ sequence (14). The sequence of the promoter-proximal A
tract loosely resembles that of a consensus UP element proximal site, but the tract is centered at ⫺47, not at ⫺40, and is
therefore rotated around the DNA compared to a typical UP
element. There is no distal site at tcpA. These observations,
along with our dominant negative data, strongly suggest that
there is no functional UP element at the tcpA promoter.
There is genetic evidence that there is an interaction between the AraC homolog RhaS and the sigma 70 subunit of
RNA polymerase (1). Bhende and Egan (1) found a specific
residue within RhaS, D241, that may be important for contacting sigma. This residue is conserved in many AraC family
members (1, 18) but not in ToxT. Because ToxT does not have
an Asp at position 241 and because its binding site does not
overlap the ⫺35 position (69), we propose that the mechanism
of ToxT-dependent activation at tcpA does not involve an interaction with sigma. This remains to be determined experimentally. Some activators are known to contact the N-terminal
domain of alpha, but an extensive genetic screening analysis
performed by Egan et al. (13) suggested that AraC family members do not use this mechanism to activate transcription (13).
Our data begin to elucidate the mechanism of ToxT-dependent transcriptional activation at the tcpA promoter, a model
of which is depicted in Fig. 8A. In our model, basal transcrip-
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FIG. 8. Model of transcriptional activation at tcpA. (A) During basal transcription, ␣CTD does not contact DNA. During activated transcription, a dimer of ToxT binds to site I (⫺82 to ⫺64) and site II (⫺59 to ⫺41). The ToxT molecule at site II recruits RNA polymerase through a
mechanism involving the ␣CTD. See text for details. ␣NTD, alpha N-terminal domain. (B) Alignment of site I and site II at tcpA, tcpI, and tagA.
Site I and site II at each promoter are underlined. The consensus sequence is shown at the bottom. An uppercase letter indicates that a base pair
is present in all three promoters, and a lowercase letter indicates that base pair is conserved in two of the three promoters.

tion at tcpA is independent of ␣CTD since there does not
appear to be a functional UP element. In order to activate
transcription, ToxT binds to an A-rich region from ⫺84 to
⫺41, the region that ToxT protected in a DNase I footprint
published recently by Yu and DiRita (69). While the footprint
defines the general region where ToxT binds, in our study we
used a mutational analysis to further investigate individual
nucleotides important for ToxT binding and activation. The
region bound by ToxT is approximately 40 bp long, which
could encompass four major grooves. Based on the AraC
model (24, 48), this provides sufficient space for one dimer of
ToxT to bind. It is not known whether ToxT is able to dimerize,
but we have found that mutations that delete either one or
both of the C-terminal HTH domains have a dominant negative phenotype with respect to tcpA expression, indicating that
there is functional multimerization of ToxT (unpublished
data). These preliminary results suggest that ToxT can dimer-

ize prior to binding DNA. The activation-defective point mutations define two small regions from ⫺65 to ⫺67 and from
⫺46 to ⫺51, and we propose that these regions represent two
of the major grooves contacted by ToxT. These major grooves
are not adjacent, further supporting the hypothesis that ToxT
binds as a dimer. Our mutational analysis did not identify the
other two major grooves contacted by ToxT, but the locations
of the two major grooves that we did identify are consistent
with two ⬃20-bp half-sites from ⫺82 to ⫺64 (site I) and from
⫺59 to ⫺41 (site II). This is similar to the AraC model (48).
The ToxT molecule centered at site II, closer to the ⫺35
region, should be in position to interact with RNA polymerase.
We have demonstrated that ToxT requires the ␣CTD of RNA
polymerase to activate transcription at tcpA (Fig. 7). It remains
to be determined experimentally whether ␣CTD contacts
DNA and/or ToxT. Figure 8B shows an alignment of the tcpA
promoter with tcpI and tagA, two other V. cholerae promoters
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that are regulated by ToxT. Similarly positioned A-rich motifs
suggest that ToxT may bind to these promoters in a similar
manner.
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